The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin–angiotensin system

By Reuter H.   Adam C.   Grönke S.   Zobel C.   Frank K.   Müller-Ehmsen J.   Brabender J.   Schwinger R.  

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3067-3074

Springer Publishing Company

Access to resources Recommend Favorite

Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

By Brillante Divina Gracilla   O'Sullivan Anthony John   Brillante Ruby Esmeralda   Howes Laurence Guy  

Blood Pressure, Vol. 18, Iss. 3, 2009-06 ,pp. : 142-148

Informa Healthcare

Access to resources Recommend Favorite

Improving Prognosis in Hypertension: Exploring the Benefits of Angiotensin II Type 1 Receptor Blockade

By RUILOPE LUIS  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite

Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O.   MOAN ANDREAS   KJELDSEN SVERRE E.  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?

By Fukui Hiroshi  

Journal of Gastroenterology, Vol. 37, Iss. 3, 2002-03 ,pp. : 235-237

Springer Publishing Company

Access to resources Recommend Favorite